ACTIVE

Ceres Invest

Financial year 2025 · Closed on 31/12/2025

Net result-1,2 M €-1 319,9 %over 1 year
Revenue2,5 M €+7,3 %over 1 year
Equity79,1 M €-1,5 %over 1 year
Workforce4,5 ETP+32,4 %over 1 year

Identity

Source · BCE/KBO

Ceres Invest is a Private limited company incorporated in 2021. Its main activity is: Activities of holding companies. Its registered office is in Gent. It employs on average 4,5 ETP workers (FTE).

Legal situation
Normal situation
BCE/KBO no. / VAT
BE 0775.683.264
Incorporation
13/10/2021
Legal form
Private limited company
Registered office
Kortrijksesteenweg 1091 box B
9051 Gent · FlandreSee on map
Contributed capital
82 363 605,13 €
Latest accounts
31/12/2025
Average workforce
4,5 ETP
Joint committees (1)
  • 200
Signals
Solid equityHealthy social debtsHigh revenue

Financials

Source · NBB, 6 filings

Trend over 4 financial years

2025202420232022
Income statement
Revenue2,5 M €2,3 M €1,9 M €1,5 M €
EBITDA-1,1 M €-8,9 k €-5,7 k €-2 M €
Operating result-1,1 M €-11,5 k €-6,4 k €-2 M €
Net result-1,2 M €-87,3 k €-26,8 k €-1,9 M €
Balance sheet
Equity79,1 M €80,4 M €75,8 M €62,4 M €
Total assets83,9 M €83,3 M €82,3 M €63,5 M €
Cash–0 €0 €509,8 k €
Debts4,7 M €2,8 M €6,5 M €1,1 M €
Other
Workforce4,5 ETP3,4 ETP2,6 ETP1,3 ETP

Valuation

Indicative valuation

As an indication, this company is worth

between 50 M€ and 100 M€
See the valuation

Board of directors

Source · NBB, accounts to 31/12/2025

4 active · 3 ended

Active mandates

NAXICAP PARTNERS

Director · since 28 octobre 2021 · 0840.340.494

Represented by Dimitri Dumoulin

Active
Axel Bernia

Director · since 13 octobre 2021

Active
Emmanuelle Pierret

Director · since 13 octobre 2021

Active
Mario Debel

Director · since 13 octobre 2021

Active

Ended mandates

Aquitania

Director · since 28 octobre 2021 · 0666.678.822

Represented by Anja Imschoot

Ended
MD CONSULT

Director · since 28 octobre 2021 · 0471.608.456

Represented by Mario Debel

Ended
NAXICAP PARTNERS

Director · since 13 octobre 2021 · 0840.340.494

Represented by Dimitri Dumoulin

Ended

Other companies at this address

Kortrijksesteenweg 1091 9051 Gent
CompanyCBE no.
2PHARMA● Active
0886.662.746
2PHARMA HOLDING● Active
0644.751.377
0474.817.869
0893.541.630
Ceres Pharma● Active
0641.953.324
0407.326.754
CONESSENCE● Active
0819.266.552
0794.812.555
0681.915.443
CREDOPHAR● Active
0849.730.193
DGPharma● Active
0508.925.544
DRIEPUNTNUL● Active
1021.711.292
HR ESSENTIALS● Active
0721.702.467
KOUTERLOS● Active
0450.036.349
Labophar● Active
0643.723.177
MD Pharma● Active
0667.779.672
PADEL FACTORY● Active
0801.951.260
0865.651.952
0884.649.304
0421.364.139

Full financial information

Source · NBB
2025202420232022
Type of accountFull modelFull modelFull modelFull model
Start of the financial year01/01/202501/01/202401/01/202313/10/2021
Closing of the financial year31/12/202531/12/202431/12/202331/12/2022
Length of the financial year12 months12 months12 months15 months
Filing date01/07/202630/07/202525/07/202429/08/2023
General meeting05/06/202630/06/202530/06/202429/08/2023
Currency of the financial yearEUREUREUREUR
NBB quality labelSatisfying controlsSatisfying controlsSatisfying controlsSatisfying controls

Financial ratios

Source · NBB

Looking for more information about this company?

Try for free

Annual accounts filings

Source · NBB, 6 filings
ModelClosingGeneral meetingFiledLanguageDocument
Full model31/12/202505/06/202601/07/2026DutchPDF
Full model31/12/202430/06/202530/07/2025DutchPDF
Consolidated accounts31/12/202415/12/202518/12/2025DutchPDF
Full model31/12/202330/06/202425/07/2024DutchPDF
Consolidated accounts31/12/202304/10/202421/10/2024DutchPDF
Full model31/12/202229/08/202329/08/2023DutchPDF

Indicative valuation

Order of magnitude

As an indication, this company is worth

between 50 M€ and 100 M€

The detail comes with the Business plan: low and high bounds, the valuation bridge for each financial year, transaction multiples by sector and size, group valuation and exports.

Discover the Business plan
Disclaimer

Indicative estimate based on public sector multiples and the filed annual accounts. It is neither a certified valuation nor financial or investment advice.

Board of directors

Source · NBB, accounts to 31/12/2025

4 active · 3 ended

Active mandates

NAXICAP PARTNERS

Director · since 28 octobre 2021 · 0840.340.494

Represented by Dimitri Dumoulin

Active
Axel Bernia

Director · since 13 octobre 2021

Active
Emmanuelle Pierret

Director · since 13 octobre 2021

Active
Mario Debel

Director · since 13 octobre 2021

Active

Ended mandates

Aquitania

Director · since 28 octobre 2021 · 0666.678.822

Represented by Anja Imschoot

Ended
MD CONSULT

Director · since 28 octobre 2021 · 0471.608.456

Represented by Mario Debel

Ended
NAXICAP PARTNERS

Director · since 13 octobre 2021 · 0840.340.494

Represented by Dimitri Dumoulin

Ended

Ownership and network

Looking for more information about this company?

Try for free

Belgian Official Gazette publications

Source · Belgian Official Gazette
  • Mandates10/03/2026
    ONTSLAGEN - BENOEMINGEN
    PDF
  • Mandates03/09/2024
    ONTSLAGEN - BENOEMINGEN
    PDF
  • Capital / shares03/06/2024
    STATUTEN (VERTALING, COÖRDINATIE, OVERIGE WIJZIGINGEN, …) - KAPITAAL - AANDELEN
    PDF
  • Capital / shares31/01/2024
    STATUTEN (VERTALING, COÖRDINATIE, OVERIGE WIJZIGINGEN, …) - KAPITAAL - AANDELEN
    PDF
  • Capital / shares11/05/2023
    STATUTEN (VERTALING, COÖRDINATIE, OVERIGE WIJZIGINGEN, …) - KAPITAAL - AANDELEN
    PDF
  • Capital / shares18/10/2022
    STATUTEN (VERTALING, COÖRDINATIE, OVERIGE WIJZIGINGEN, …) - KAPITAAL - AANDELEN
    PDF
  • Registered office19/04/2022
    MAATSCHAPPELIJKE ZETEL
    PDF
  • Mandates24/11/2021
    STATUTEN (VERTALING, COÖRDINATIE, OVERIGE WIJZIGINGEN, …) - KAPITAAL - AANDELEN - ONTSLAGEN - BENOEMINGEN
    PDF

Similar companies

A company's peers, by sector and size, are included in the Business plan.

See the Business plan

Timeline

  1. 2025
    Annual accounts 2025-1,2 M €↓
  2. 30/06/2025
    nominationWouter Coppens — commissaris
  3. 2024
    Annual accounts 2024-87,3 k €↓
  4. 13/05/2024
    augmentation_capital
  5. 2023
    Annual accounts 2023-26,8 k €↑
  6. 01/07/2023
    nominationWouter Coppens — commissaris
  7. 04/05/2023
    augmentation_capital
  8. 2022
    Annual accounts 2022-1,9 M €
  9. 13/10/2021
    IncorporationPrivate limited company